References in the content below refer to the PBMEF Guide.
Definitions
Percentage of laboratory-confirmed pulmonary RR-TB/MDR-TB cases tested for susceptibility to second-line TB drugs (fluoroquinolones) among lab-confirmed pulmonary RR-TB/MDR- TB notified cases during the reporting period.
Numerator
Number of new or previously treated bacteriologically confirmed pulmonary TB patients with resistance to rifampicin and with test results for any fluoroquinolones during reporting period. WHO database: rr_dst_rlt_fq
Denominator
Number of new or previously treated bacteriologically confirmed pulmonary RR-TB/MDR-TB notified cases during the reporting period. WHO database: rr_new PLUS rr_ret
Ref # |
(Previously RN-3) |
Tier Level |
Extended Indicator
|
Data Type |
Percentage
|
Disaggregations |
N/A |
There are no related indicators for this indicator.